8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2013 / Narrative review
This review evaluates the evidence connecting sodium intake, blood pressure, and vascular risk. The authors state there is unequivocal evidence that increased sodium intake is associated with higher blood pressure and that increased blood pressure leads to higher vascular disease risk, but direct evidence linking sodium intake to vascular risk is inconsistent and confusing. The review considers how vested interests have exploited this inconsistency and argues that legislation is the only tool likely to reduce this dietary additive.
Neal B, Land MA, Woodward M Curr Hypertens Rep, 2013. PMID 24170199
2013 / Narrative review
This review explores the effects of maternal dietary polyphenols on the fetal ductus arteriosus during late pregnancy. The ductus arteriosus directs 80-85% of right ventricular output to the descending aorta, and constriction can cause complications such as heart failure, hydrops, neonatal pulmonary hypertension, and death. Evidence suggests that herbs, fruits, nuts, and polyphenol-rich foods possess anti-inflammatory actions that inhibit prostaglandin synthesis, potentially altering ductal flow dynamics during the third trimester.
Zielinsky P, Busato S Birth Defects Res C Embryo Today, 2013. PMID 24339037
2013 / Narrative review
This review discusses the emerging clinical problem of type 2 diabetes mellitus in children and adolescents, noting an increasing global prevalence across ethnicities even where obesity rates have plateaued. High-risk groups include specific ethnic minorities, youth with obesity, family history of type 2 diabetes, or signs of insulin resistance. Screening is considered meaningful due to frequent mild or asymptomatic presentations. Lifestyle intervention is highlighted as the primary treatment of choice, followed by pharmacological options such as metformin.
Reinehr T World J Diabetes, 2013. PMID 24379917
2013 / Expert panel consensus guideline update
An expert panel updated the 2002 consensus guidelines on medical fasting therapy. Fasting demonstrates beneficial effects in various chronic diseases, with the highest level of evidence observed for rheumatic diseases. Preliminary data also indicate benefits for metabolic diseases, hypertension, pain syndromes, chronic inflammatory diseases, atopic diseases, psychosomatic disorders, and disease prevention in healthy individuals. The panel states that fasting interventions should be guided by trained and certified physicians or therapists to ensure safety and quality standards.
Wilhelmi de Toledo F, Buchinger A, Burggrabe H, et al. Forsch Komplementmed, 2013. PMID 24434758
2013 / Narrative review
This review evaluates the evidence surrounding deliberate and medically supervised modified fasting (200-500 kcal/day for 7-21 days) for disease prevention and treatment. Observational and empirical evidence suggests efficacy in rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome, with randomized controlled trials confirming benefits of fasting followed by a vegetarian diet in rheumatoid arthritis. Additionally, intermittent fasting is associated with deceleration or prevention of chronic degenerative diseases and may serve as an adjunct to cancer chemotherapy.
Michalsen A, Li C Forsch Komplementmed, 2013. PMID 24434759
2012 / Program evaluation / narrative review
This paper describes the UK Food Standards Agency's salt reduction programme between 2003 and 2010. Urinary sodium data showed a statistically significant reduction in average adult salt intake from 9.5 g/d in 2000-2001 to 8.6 g/d in 2008. Food monitoring showed reductions up to 70% in some items, and consumer awareness increased, with 43% of adults in 2009 claiming to make an effort to reduce dietary salt compared to 34% in 2004. Significant challenges remain in achieving the recommended population average of 6 g/d.
Wyness LA, Butriss JL, Stanner SA Public Health Nutr, 2012. PMID 21729460
2012 / Narrative review
This review summarizes scientific literature on Cinnamomum aromaticum (Cassia) and Cinnamomum zeylanicum bark products. While in vitro and animal studies consistently demonstrated pronounced anti-diabetic and hypoglycemic activities alongside potential antimicrobial, antioxidant, and lipid-lowering properties, results from available human clinical trials remain conflicting. The authors emphasize the need for well-defined, adequately powered randomized controlled clinical trials before recommending cinnamon as an effective human treatment.
Bandara T, Uluwaduge I, Jansz ER Int J Food Sci Nutr, 2012. PMID 22007625
2012 / Narrative review
This review evaluates the evidence and mechanisms of cinnamon for managing insulin resistance, metabolic syndrome, and type 2 diabetes. Human clinical trials have yielded mixed results; while some showed no benefits, others noted improvements in cholesterol, systolic blood pressure, insulin sensitivity, and postprandial glucose. However, the only outcome consistently improved by cinnamon consumption across trials was fasting glucose levels. The authors note it is premature to suggest cinnamon supplementation based on the current evidence, and systematic large-scale clinical trials are needed.
Rafehi H, Ververis K, Karagiannis TC Diabetes Obes Metab, 2012. PMID 22093965
2012 / Narrative review
Non-communicable diseases (NCDs) like cardiovascular disease, cancer, and diabetes have shown a dramatic increase in the developing world, particularly in highly populated transition countries. Almost 4 out of 5 NCD-based deaths now occur in low- and middle-income countries. This trend is driven by factors including globalization, supermarket growth, rapid urbanization, and sedentary lifestyles leading to overweight or obesity. A high-quality diet including functional food or ingredients, physical activity, and non-smoking policies are noted as promising preventive strategies.
Wagner KH, Brath H Prev Med, 2012. PMID 22178469
2012 / Narrative review
This review describes the global nutrition transition that began in the 1970s, characterized by shifts toward processed foods, away-from-home intake, edible oils, and sugar-sweetened beverages alongside decreased physical activity. Rapid increases in obesity and overweight are now documented globally, including in urban and rural areas of the poorest countries in sub-Saharan Africa and South Asia. Despite these widespread dietary and activity challenges, few countries are currently engaged in serious preventive efforts.
Shows an association, not proof of cause and effect.
Popkin BM, Adair LS, Ng SW Nutr Rev, 2012. PMID 22221213
2012 / Narrative review
This review evaluated evidence on inadequate sleep as a risk factor for obesity and cardiometabolic disease. Experimental studies reported that short-term sleep restriction is associated with impaired glucose metabolism, dysregulation of appetite, and increased blood pressure. Observational studies reported associations between short sleep duration (<6 h per night) and increased body mass index, obesity, prevalent diabetes, and hypertension, with some studies also linking long sleep (>8 h per night) to cardiometabolic disease. A few prospective studies found an increased risk of weight gain, incident diabetes, and incident hypertension associated with inadequate sleep.
Shows an association, not proof of cause and effect.
Knutson KL Am J Hum Biol, 2012. PMID 22275135
2012 / Review
This review evaluates evidence on quercetin's potential therapeutic role and blood pressure-lowering mechanisms. The authors note that work in hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic) indicates a decrease in blood pressure after quercetin supplementation. Proposed mechanisms include antioxidant effects, inhibition of angiotensin-converting enzyme activity, and improved endothelial function, though most mechanisms have been identified in animal models and relatively few have been corroborated in humans.
Larson AJ, Symons JD, Jalili T Adv Nutr, 2012. PMID 22332099
2012 / Narrative review
This review discusses the health implications of inadequate dietary fiber intake. Evidence points to an association between a lack of fiber intake and conditions such as ischemic heart disease, stroke, type 2 diabetes, obesity, hypertension, and gastrointestinal disorders. Beyond physical properties that influence food energy density, fiber directly impacts microbiological, biochemical, and neurohormonal effects through modified digestion kinetics and metabolism into short-chain fatty acids. Consequently, functional fiber supplementation may play an important role in long-term obesity management via glucoregulation, appetite, and satiety.
Shows an association, not proof of cause and effect.
Lyon MR, Kacinik V Curr Obes Rep, 2012. PMID 22611521
2012 / Narrative review / roundtable summary
A roundtable session gathered nutrition researchers, educators, and communicators to evaluate solutions for the American dietary fiber gap. Despite promotion over the past decade, fiber intake has remained flat at roughly half of daily recommendations, leaving over 90% of adults and children short of targets. The discussions emphasized consumer and professional education to enhance acceptance and inclusion of grain-based foods with added fiber as a realistic approach to boost intake within daily energy goals.
Clemens R, Kranz S, Mobley AR, et al. J Nutr, 2012. PMID 22649260
2012 / Authors' perspective review
This perspective review evaluated evidence regarding the optimal intake of vitamin C in humans, arguing that standard Phase III drug trials are ill-suited for essential nutrients. The authors noted that evidence from prospective cohort studies and Phase II RCTs indicates vitamin C supplementation reduces hypertension, endothelial dysfunction, chronic inflammation, and Helicobacter pylori infection. Based on combined data from human metabolic, pharmacokinetic, observational, and Phase II studies, the authors conclude that 200 mg/day is the optimum intake for most adults to maximize health benefits with minimal risk.
Frei B, Birlouez-Aragon I, Lykkesfeldt J Crit Rev Food Sci Nutr, 2012. PMID 22698272
2012 / Narrative review
This review examines maternal risks associated with carrying multiple gestations. Compared with singleton pregnancies, twin pregnancies present increased maternal risks across antepartum, intrapartum, and postpartum periods, including preeclampsia, other hypertensive disorders, antepartum hospitalization for preterm labor or abnormal bleeding, nutritional deficiencies, cesarean delivery, and postpartum hemorrhage. The review notes that women carrying twins may benefit from early education, close monitoring, physical therapy, and nutrition counseling.
Young BC, Wylie BJ Semin Perinatol, 2012. PMID 22713496
2012 / Narrative review
This review examined the health benefits of viscous versus nonviscous soluble fibers based on scientific literature and evidence-based guidelines. The authors concluded that many health benefits of fiber directly correlate with the viscosity of soluble fibers when hydrated. Clinically, increasing chyme viscosity with viscous soluble fiber lowers cholesterol, improves glycemic control in type 2 diabetes, normalizes stool form in constipation and diarrhea, and improves clinical measures of metabolic syndrome such as lipoproteins, glycemic control, BMI/weight, and blood pressure.
Chutkan R, Fahey G, Wright WL, et al. J Am Acad Nurse Pract, 2012. PMID 22845031
2012 / Narrative review
This review discusses dietary salt intake reduction in hypertensive patients. Recent meta-analyses of randomized controlled trials cited in the text indicate that moderate salt reduction is associated with reduced blood pressure and, in perspective, reduced cardiovascular and cerebrovascular events in hypertensive individuals. Patient response to salt reduction varies, primarily due to inconsistent compliance and, to a lesser extent, individual differences in blood pressure salt sensitivity.
Strazzullo P, D'Elia L, Cairella G, et al. High Blood Press Cardiovasc Prev, 2012. PMID 22867091
2012 / Narrative review
This review examines epidemiological evidence on dietary fiber intake and cardiovascular disease (CVD) risk. Substantial epidemiological evidence shows an inverse association between dietary fiber intake and CVD risk, with a stronger link for cereal fiber than for fruit or vegetable fiber. Increased whole grain consumption has also been linked to CVD risk reduction, potentially via mechanisms such as lipid reduction, body weight regulation, glucose metabolism, blood pressure control, and lower chronic inflammation.
Shows an association, not proof of cause and effect.
Satija A, Hu FB Curr Atheroscler Rep, 2012. PMID 22872372
2012 / Narrative review
This review evaluates whether vascular disease contributes to Alzheimer's disease (AD). It considers how modifiable risk factors including hypertension, atherosclerosis, diabetes, dyslipidaemia, and adiposity impact vascular structure and function. Human and animal findings indicate that vascular pathology leads to chronic cerebral hypoperfusion, which induces AD features such as selective brain atrophy, white matter changes, and amyloid beta accumulation. Evidence also suggests interventions that improve vascular function attenuate AD pathology.
Kalaria RN, Akinyemi R, Ihara M J Neurol Sci, 2012. PMID 22884479
2012 / Narrative review
Despite increased life expectancy, chronic diseases such as heart disease, cancer, diabetes, hypertension, and obesity have risen in the US and globally. This review examines how modern therapies and western lifestyles contribute to a decline in nitric oxide (NO) homeostasis from pediatrics to geriatrics. The author notes that standard laboratory diagnostics for NO status and prescription therapies to safely restore NO homeostasis are currently lacking in clinical settings.
Bryan NS Pharmacol Res, 2012. PMID 23044353
2012 / Consensus statement / narrative review
This American Heart Association statement reviewed recent controversial observational studies and a meta-analysis questioning recommendations to lower sodium intake. The review noted substantial methodological concerns that limit the usefulness of those studies in setting or reversing dietary guidance. The authors concluded that the evidence base supporting reduced sodium intake for the general population remains persuasive and reaffirmed the AHA recommendation to reduce dietary sodium intake to <1500 mg/d.
Whelton PK, Appel LJ, Sacco RL, et al. Circulation, 2012. PMID 23124030
2012 / Historical and policy review
This review explores the four-decade-long scientific controversy regarding the extent to which elevated salt consumption contributes to adverse population health, stroke, and cardiovascular disease. Although studies and trials have yielded conflicting results, public health leaders have continued to promote population-level salt reduction. The authors argue that concealing scientific uncertainty has harmed both scientific progress and sound policy, highlighting the challenge of formulating evidence-based policy from contested data.
Bayer R, Johns DM, Galea S Health Aff (Millwood), 2012. PMID 23213158
2011 / Narrative review and hypothesis
Diabetic nephropathy is increasingly driving end-stage renal failure worldwide. The authors note that Western dietary habits are shifting toward more acidifying foods, and diet acculturation may contribute to an up to 40 times higher chance of developing diabetic end-stage renal failure among South-Asian immigrants compared with whites in Western countries. High dietary acid intake leads to compensatory renal acid excretion and ammoniagenesis, resulting in tubulointerstitial injury, reduced renal function, and hypertension. The authors hypothesize that promoting a shift toward more alkalinizing foods could correct this tendency for metabolic acidosis and prevent the epidemic of end-stage renal disease in diabetes.
van den Berg E, Hospers FA, Navis G, et al. J Nephrol, 2011. PMID 20872351